ScholarWorks@Korea University College of Medicine: Park, Dae Won

Detailed Information

Park, Dae Won (박대원)

Ansan Hospital (Department of Infectious Diseases, Ansan Hospital)

Research Area: 패혈증, 감염관리, 결핵, Sepsis, Infection Control, Tuberculosis

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Sepsis:9||mortality:7||Septic shock:7||septic shock:6||sepsis:5||Procalcitonin:4||Vaccination:4||Korea:4||risk factors:4||Bacteremia:4||Risk factors:4||Influenza:4||Pyelonephritis:3||Acinetobacter baumannii:3||Human immunodeficiency virus:3||HIV:3||Immunogenicity:3||COVID19:3||Mortality:3||Epidemiology:3||infection control:3||Hepatitis A:3||Elderly:2||piperacillintazobactam:2||Urinary tract infection:2||epidemiology:2||Methicillinresistant Staphylococcus aureus:2||Acute pyelonephritis:2||Vaccine:2||Safety:2||Emergency department:2||MRSA:2||Communicable diseases:2||safety:2||Antibacterial agents:2||Organ dysfunction scores:2||Communityacquired pneumonia:2||Antibiotics:2||ICU:2||Staphylococcus aureus:2||Disease outbreaks:2||Genotype:2||Surveillance:2||Escherichia coli:2||immunogenicity:2||Prognosis:2||treatment:2||Legionella pneumophila:2||tuberculosis:2||inflammation:2||2009 H1N1:2||Measles:2||Tuberculosis:2||AIDSrelated opportunistic infections:2||Infection control:2||mupirocin:2||Control:1||Corticosteroid:1||Cysticercosis:1||Cystitis:1||DHA1:1||Dementia:1||Diabetes mellitus:1||Diagnosis:1||Diagnostic imaging:1||Disease Outbreaks:1||Drug resistance:1||Duration of treatment:1||E:1||E. coli:1||EMA:1||EMERGENCE:1||Effectiveness:1||Empyema:1||Endocarditis:1||Enhanced environmental cleaning:1||Ertapenem:1||Etiology:1||European Medicines Agency:1||Extrapulmonary tuberculousis:1||Fasciitis:1||Fosfomycin:1||Fungemia:1||Fusariosis:1||GENNOV:1||GMT:1||GMTR:1||GSK3 beta:1||Gastroenteriris:1||Gender:1||Guideline:1||H1N1:1||H1N1 subtype:1||HETERORESISTANCE:1||HIV Infection:1||HIV infection:1||HOSPITALS:1||Hantaan virus:1||Hantann virus:1||Hantavirus:1||Health Personnel:1||Healthcareassociated infection:1||Hemolytic anemia:1||Hepatitis B Virus:1||Hepatitis B virus:1||Hepatitis C virus:1||Histiocytic necrotizing lymphadenitis:1||Histoplasma capsulatum:1||ICUs:1||IKK:1||INFECTIONS:1||Immune cell:1||Infection Control:1||Influenza A virus:1||Initial therapeutic regimen:1||Interleukin6:1||KOREA:1||Kidney:1||Klebsiella pneumoniae:1||Korea HIV:1||Lactococcus lactis:1||Legionella:1||Legionnaires' disease:1||Leptospira:1||Linezolid:1||Liposomal amphotericin B:1||Liver Abscess:1||Loss to follow up:1||MIC:1||MODEL:1||Machine learning:1||Malignant pleural effusion:1||MeaslesMumpsRubella Vaccine:1||Measlesmumpsrubella vaccine:1||Metabolism:1||Methicillin Resistance:1||Methicillinresistant Staphylococcus aureus (MRSA):1||Minimal Inhibitory Concentration:1||Mitochondria:1||Multiorgan failure:1||Multicenter cohort:1||Multidrug resistant organisms:1||Multilocus sequence typing:1||Mycobacterium abscessus:1||National Cohort:1||Neonate:1||Neurosurgery:1||Neutralization tests:1||Nitrofurantoin:1||Olfaction Disorders:1||Opportunistic infection:1||Organ failure:1||Orientia tsutsugamushi:1||Otolaryngology:1||Outbreak:1||Outbreaks:1||PARK2:1||PRSP:1||PSEUDOMONASVESICULARIS:1||Pandemics:1||Pantonvalentine leukocidin (PVL):1||Pentraxin 3:1||Pertussis Seroprevalence:1||Plasmodium vivax:1||Pneumococcal infections:1||Poorly differentiation攀접수일자: 2002년 2월 5일통과일자: 2002년 2월 25일:1||Pregnancy:1||Presepsin:1||Prevalence:1||Prevention and control:1||Prognostic factors:1||Prostatitis:1||Proteasome:1||Pure red cell aplasia:1||QIV:1||RIII:1||RIFAMPICIN:1||Racemose:1||Recurrence:1||Registry:1||Renal insufficiency:1||Republic of Korea:1||Residual lymph node:1||Risk Factor:1||Risk factor:1||Rotavirus:1||SARSCoV2:1||SEPTICEMIA:1||SHV12:1||SIRS:1||SOFA score:1||SYNERGY:1||Scrub typhus:1||Septic:1||Septic Shock:1||Sequential Organ Failure Assessment score:1||Seroepidemiology study:1||Severe Sepsis:1||Severe sepsis:1||Shock:1||Shortterm mortality:1||Small hospital:1||Soft tissue infection:1||Stockraising:1||Streptococcus pneumoniae:1||Subarachnoid:1||Suprasellar Tumor:1||Surgical site infection:1||Surviving Sepsis Campaign guidelines:1||Systemic inflammatory response syndrome:1||TIV:1||Taste Disorders:1||Temocillin:1||Thrombophlebitis:1||Thyroid papillary carcinoma:1||Tolllike receptors:1||Tomography scanners Xray computed:1||Treatment outcome:1||TrimethoprimSulfamethoxazole combination:1||Tsutsugamushi:1||Ubiquitination:1||Ultrasonography:1||Urinary Tract:1||Urinary Tract Infections:1||VRE:1||Vaccine immunogenicity:1||Vaccines:1||Vancomycin resistance:1||Vi capsular polysaccharide typhoid vaccine:1||Women:1||Yersinia:1||Yersinia infections:1||Yersinia pseudotuberculosis:1||absolute CD4 count:1||acquired immunodeficiency syndrome:1||acute lung injury:1||acute pyelonephritis:1||acute respiratory distress syndrome:1||acute respiratory infections:1||adjuvanted recombinant zoster vaccine:1||alanine aminotransferase:1||antibacterial agents:1||antibody test:1||antigens:1||avidity:1||bacteremia:1||bacterial drug resistance:1||betalactamases:1||biomarker:1||blood transfusion:1||cDNA microarray:1||casecontrol study:1||cefixime:1||cephalosporins:1||coli:1||colonization:1||combination:1||combination therapy:1||computed tomography:1||cutaneous infection:1||drug resistance:1||early clinical failure:1||emergency department:1||enterococcus:1||extracorporeal membrane oxygenation:1||flow cytometry:1||fluoroquinolone:1||fosfomycin:1||gastric surgery:1||genotype:1||geometric mean titer:1||geometric mean titer ratio:1||hepatitis:1||hepatitis A virus:1||human:1||human immunodeficiency virus:1||immune response persistence:1||immunocompromised host:1||in vitro timekill:1||influenza vaccines:1||inotropes:1||isoleucinetRNA ligase:1||lactate:1||lactate clearance:1||lipopolysaccharide:1||lipoproteins:1||longterm efficacy:1||lot consistency:1||lung fibrosis:1||lymph nodes:1||macrophages, peritoneal:1||malaria antibody:1||microchip:1||microscopic cell counter:1||minimum inhibitory concentration:1||missense:1||morbidity:1||moxifloxacin:1||mumps:1||mutation:1||neck:1||older adults:1||outbreak:1||outcome:1||patientreported outcome:1||plasmid:1||prognosis:1||pyelonephritis:1||quadrivalent influenza vaccine:1||quality of life:1||resistance:1||respiratory syncytial virus:1||risk factor:1||severe sepsis:1||severity:1||spine:1||spread:1||standardized mortality ratio:1||stellate cells:1||survival:1||the Separation of Prescription and Drug Selling:1||timeseries analysis:1||transfusion:1||trivalent influenza vaccine:1||urinary tract infection:1||vaccine failure:1||vasopressors:1||vitamin D:1||vitamin D deficiency:1||패혈쇼크:1||패혈증:1||AIDS cohort:1||AMP kinase:1||AMPK:1||Acinetobacter infections:1||Acute kidney injury:1||Adverse Event:1||Albendazole:1||Alzheimer:1||Amikacin:1||Anemia:1||Antiinfective agents:1||Antiretroviral agents:1||Antibacterial agents:1||Antibiotic resistance:1||Antibiotic stewardship:1||Antibody affinity:1||Antimicrobial Stewardship:1||Antimicrobial resistance:1||Antimicrobial stewardship:1||Antimicrobial susceptibility:1||Antimicrobial utilization:1||Antiretroviral therapy:1||Antiretroviral therapy highly active:1||Antituberculous treatment:1||Autonomic Dysfunction:1||Autophagy:1||BACTEREMIA:1||Bioenergetics:1||Biomarker:1||Biomarkers:1||Blood culture:1||Bromocriptine:1||Brucellosis:1||Byproduct:1||Creactive protein:1||CD4:1||CD4 lymphocyte count:1||CD4+ Lymphocyte Count:1||CHILD:1||COMBNOV:1||COMBINATION:1||Casecontrol studies:1||Cefepime:1||Ceftriaxone:1||Central Fever:1||Cervical tuberculous lymphadenitis:1||Chylothorax:1||Chylous ascites:1||Ciprofloxacin:1||CoInfection:1||Cohort Study:1||Coinfection:1||Combination drug therapy:1||CommunityAcquired Infections:1||Communityacquired infections:1||

STATISTICS: Total View :12,667,070; Today View :4,298

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE